Verrica Pharmaceuticals SG&A Expense (TTM) Insights

Verrica Pharmaceuticals Inc (VRCA)

1.69 +0.01 (+0.60%) USD | NASDAQ | Sep 27, 16:00

1.66 -0.03 (-1.78%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	69.91M
March 31, 2024	59.32M
December 31, 2023	47.30M
September 30, 2023	33.50M
June 30, 2023	17.37M
March 31, 2023	16.61M
December 31, 2022	17.40M
September 30, 2022	19.33M
June 30, 2022	23.41M
March 31, 2022	25.52M
December 31, 2021	26.98M
September 30, 2021	31.63M
June 30, 2021	28.27M
March 31, 2021	26.10M

Date	Value
December 31, 2020	24.51M
September 30, 2020	18.76M
June 30, 2020	17.61M
March 31, 2020	16.09M
December 31, 2019	14.64M
September 30, 2019	13.90M
June 30, 2019	13.27M
March 31, 2019	11.63M
December 31, 2018	9.052M
September 30, 2018	6.097M
June 30, 2018	3.47M
March 31, 2018	1.633M
December 31, 2017	0.727M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

13.90M

Minimum

Sep 2019

69.91M

Maximum

Jun 2024

27.41M

Average

23.96M

Median

SG&A Expense (TTM) Benchmarks